Episode 132

full
Published on:

30th Nov 2023

ENDRA Life Sciences, Inc. (NDRA) Francois Michelon, CEO

The pioneer of Thermo Acoustic Enhanced

UltraSound (TAEUS®), a

ground-breaking technology which characterizes tissue similar to an MRI, but at

1/50th the cost

and at the point of patient care. TAEUS® is designed to work in concert with the more than 700,000

ultrasound systems in use globally today. TAEUS® is initially focused on the measurement

of fat in the liver as a means to assess and monitor steatotic liver disease

(SLD) (formerly known as NAFLD-NASH), a chronic liver disease spectrum that

affects over two billion people globally, and for which there are no practical

diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical

applications of TAEUS®, including

visualization of tissue temperature during energy-based surgical procedures.

Next Episode All Episodes Previous Episode

Listen for free

Show artwork for The Wall Street Resource

About the Podcast

The Wall Street Resource
Your resource for microcap discovery and due diligence
As part of the investment process, we have conducted countless CEO and executive interviews, and found this to be an invaluable use of time. We provide The Wall Street Resource, not only to help you leverage your time, but for discovery and a starting point for due diligence.

About your host

Profile picture for Jeffrey Kone

Jeffrey Kone

Managing Member and portfolio manager of a micro-cap fund for over 15 years. Securities experience that encompasses almost all aspects of the industry (buy side, sell side, retail, institutional and investment banking). Degree from University of Southern California with a Bachelor of Science in Business, emphasis in Entrepreneurship.